Product Program year 2023 Source: CMS Open Payments

Liposober

Device

Open in the dashboard

General payments

$320,657

44 payments

Research payments

$0

0 payments

Through program year 2023, $320,657 in general payments and $0 in research payments were reported against Liposober.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2023 General $2,750 1
2022 General $317,907 43

Breakdown

Who paid General payments · program years 2022–2023
  1. Kaneka Pharma America LLC $320,657 44 payments
Top recipients General payments · program year 2022
  1. Mount Sinai Hospital Teaching hospital · NY $75,000 24% · 1 payment
  2. Patrick Moriarty Clinical Pharmacology · Kansas City, KS $61,932 19% · 1 payment
  3. Mayo Clinic Hospital Teaching hospital · AZ $51,129 16% · 1 payment
  4. University Of Minnesota Medical Ctr Teaching hospital · MN $20,950 7% · 1 payment
  5. University Of Miami Hosp & Clinics Teaching hospital · FL $14,386 5% · 1 payment

The top 5 of 43 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Clinical Pharmacology $61,932 73% · 1 practitioner
  2. Pediatric Nephrology Pediatrics $11,625 14% · 3 practitioners
  3. Cardiovascular Disease Internal Medicine $7,500 9% · 4 practitioners
  4. Nurse Practitioner, Adult Health Nurse Practitioner $1,750 2% · 1 practitioner
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $1,500 2% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. New York $79,495 25% · 4 recipients
  2. Kansas $61,932 19% · 1 recipient
  3. Arizona $51,269 16% · 2 recipients
  4. Minnesota $21,805 7% · 3 recipients
  5. California $16,808 5% · 5 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

44 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record